Belatacept for kidney transplant recipients

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|10|752-754

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.10, 2015-10, pp. : 752-754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does belatacept improve outcomes for kidney transplant recipients? A systematic review

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 934-0874, Iss. 11, 2015-11 ,pp. : 1251-1264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does belatacept improve outcomes for kidney transplant recipients? A systematic review

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 11, 2015-11 ,pp. : 1251-1264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time‐Varying Belatacept Exposure and Its Relationship to Efficacy/Safety Responses in Kidney‐Transplant Recipients

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 251-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 10, 2015-10 ,pp. : 2726-2731

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcome of belatacept therapy in de novo kidney transplant recipients – a case‐match analysis

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 7, 2015-07 ,pp. : 820-827

John Wiley & Sons Inc

Access to resources Recommend Favorite